These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36528602)

  • 1. Effect of methylphenidate on functional controllability: a preliminary study in medication-naïve children with ADHD.
    Henry TR; Fogleman ND; Nugiel T; Cohen JR
    Transl Psychiatry; 2022 Dec; 12(1):518. PubMed ID: 36528602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K; Halari R; Cubillo A; Mohammad AM; Brammer M; Taylor E
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review.
    Czerniak SM; Sikoglu EM; King JA; Kennedy DN; Mick E; Frazier J; Moore CM
    Harv Rev Psychiatry; 2013; 21(3):151-62. PubMed ID: 23660970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased default-mode variability is related to reduced task-performance and is evident in adults with ADHD.
    Mowinckel AM; Alnæs D; Pedersen ML; Ziegler S; Fredriksen M; Kaufmann T; Sonuga-Barke E; Endestad T; Westlye LT; Biele G
    Neuroimage Clin; 2017; 16():369-382. PubMed ID: 28861338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate remediates aberrant brain network dynamics in children with attention-deficit/hyperactivity disorder: A randomized controlled trial.
    Mizuno Y; Cai W; Supekar K; Makita K; Takiguchi S; Tomoda A; Menon V
    Neuroimage; 2022 Aug; 257():119332. PubMed ID: 35640787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder.
    Quinn D; Wigal S; Swanson J; Hirsch S; Ottolini Y; Dariani M; Roffman M; Zeldis J; Cooper T
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1422-9. PubMed ID: 15502602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
    Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate.
    Wu ZM; Bralten J; An L; Cao QJ; Cao XH; Sun L; Liu L; Yang L; Mennes M; Zang YF; Franke B; Hoogman M; Wang YF
    J Psychopharmacol; 2017 Aug; 31(8):1061-1069. PubMed ID: 28656805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorder.
    An L; Cao XH; Cao QJ; Sun L; Yang L; Zou QH; Katya R; Zang YF; Wang YF
    Neuropsychopharmacology; 2013 Jun; 38(7):1287-95. PubMed ID: 23340519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Huang YS; Yeh CB; Chen CH; Shang CY; Gau SS
    J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):164-178. PubMed ID: 33395356
    [No Abstract]   [Full Text] [Related]  

  • 11. Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder.
    Froehlich TE; Antonini TN; Brinkman WB; Langberg JM; Simon JO; Adams R; Fredstrom B; Narad ME; Kingery KM; Altaye M; Matheson H; Tamm L; Epstein JN
    J Dev Behav Pediatr; 2014; 35(2):100-7. PubMed ID: 24509055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder.
    Rosch KS; Fosco WD; Pelham WE; Waxmonsky JG; Bubnik MG; Hawk LW
    J Abnorm Child Psychol; 2016 Feb; 44(2):309-21. PubMed ID: 25985978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of single-dose methylphenidate on resting-state network functional connectivity in ADHD.
    Silk TJ; Malpas C; Vance A; Bellgrove MA
    Brain Imaging Behav; 2017 Oct; 11(5):1422-1431. PubMed ID: 27734305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate improves some but not all measures of attention, as measured by the TEA-Ch in medication-naïve children with ADHD.
    Paton K; Hammond P; Barry E; Fitzgerald M; McNicholas F; Kirley A; Robertson IH; Bellgrove MA; Gill M; Johnson KA
    Child Neuropsychol; 2014; 20(3):303-18. PubMed ID: 23639119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of methylphenidate on social cognition and oxytocin in children with attention deficit hyperactivity disorder.
    Levi-Shachar O; Gvirts HZ; Goldwin Y; Bloch Y; Shamay-Tsoory S; Zagoory-Sharon O; Feldman R; Maoz H
    Neuropsychopharmacology; 2020 Jan; 45(2):367-373. PubMed ID: 31514201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain tissue iron neurophysiology and its relationship with the cognitive effects of dopaminergic modulation in children with and without ADHD.
    Cascone AD; Calabro F; Foran W; Larsen B; Nugiel T; Parr AC; Tervo-Clemmens B; Luna B; Cohen JR
    Dev Cogn Neurosci; 2023 Oct; 63():101274. PubMed ID: 37453207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder.
    Bouziane C; Filatova OG; Schrantee A; Caan MWA; Vos FM; Reneman L
    Radiology; 2019 Oct; 293(1):186-192. PubMed ID: 31407970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Greenhill LL; Nordbrock E; Connor DF; Kollins SH; Adjei A; Childress A; Stehli A; Kupper RJ
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):562-9. PubMed ID: 25470572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
    Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
    Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.